In these women, >20% epithelial expression of EZH2 was associated with a 3.15-fold increase in breast cancer risk (OR = 3.15, 95% CI 1.39–7.14), relative to women with <10% expression of EZH2. This evidence concerns the gene EZH2 and breast cancer.